Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals Private Limited - chemicals in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24233UP2015PTC073968 Incorporated 20 October 2015 ROC Kanpur HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2024
₹9.11 Lakh
▼ 15% YoY
Net profit · FY 2024
₹6,955
Net margin 0.8%
EBITDA · FY 2024
₹6,955
EBITDA margin 0.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Adils Pharmaceuticals Private Limited

Data last updated:

Adils Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 October 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2015PTC073968. Its GSTIN is 09AANCA8638E1ZB (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lalita Roy and Mano Ranjan Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 246 C 1 Lda Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.

As per the financials filed for FY 2024, the company reported a revenue of ₹9.11 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹6,955 (net margin 0.8%) and EBITDA of ₹6,955 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 26% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Adils Pharmaceuticals Private Limited
CIN U24233UP2015PTC073968
Registration Number 073968
Incorporation Date 20 October 2015
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    246 C 1 Lda Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Adils Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Adils Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Adils Pharmaceuticals Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Adils Pharmaceuticals Private Limited

The main business activity of Adils Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Adils Pharmaceuticals Private Limited FY 2025 filings available

Adils Pharmaceuticals Private Limited reported revenue of ₹9.11 Lakh (down 15% YoY) for FY 2024.

Revenue · FY 2024
₹9.11 Lakh ▼ 15%
Net profit · FY 2024
₹6,955 margin 0.8%
EBITDA · FY 2024
₹6,955 margin 0.8%

Compounded Annual Growth Rate (CAGR) of Adils Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 9%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 20%
5 years · compounded
▼ 24%

Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Adils Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹6,955••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹6,955••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Adils Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0.8%••••••••••••••••
Net Profit Margin0.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Adils Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lalita RoyDirector20 Oct 201511 Years 0 MonthsCurrent
Mano Ranjan KumarDirector10 Apr 20233 Years 6 MonthsCurrent

Peer Comparison of Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Exevant Pharmaceuticals Private Limited₹9.12 Lakh (FY 2025)••••••••7.0%••••Sikar, Rajasthan, India
Sigmavet Pharmaceuticals Private Limited₹9.11 Lakh (FY 2024)••••••••••••Raebareilly, Uttar Pradesh, India
Healthon Pharmaceuticals Private Limited₹9.11 Lakh (FY 2016)••••••••9.0%••••Kochi, Kerala, India
Atbu Harita Pharmaceuticals Private Limited₹9.11 Lakh (FY 2024)••••••••-9.0%••••Vyara, Gujarat, India
Livway Pharmaceuticals Private Limited₹9.11 Lakh (FY 2025)••••••••33.0%••••Delhi, India
Adils Pharmaceuticals Private Limited this company₹9.11 Lakh (FY 2024)••••••••-15.0%••••Lucknow, Uttar Pradesh, India
Hari Cure Pharmaceuticals Private Limited₹9.07 Lakh (FY 2025)••••••••-30.0%••••Patna, Bihar, India
Elixir Pharmaceuticals Private Limited₹9.07 Lakh (FY 2025)••••••••-41.0%••••Gurgaon, Haryana, India
Freefind Pharmaceuticals Private Limited₹9.07 Lakh (FY 2024)••••••••••••Aligarh, Uttar Pradesh, India
Triozone Pharmaceuticals Private Limited₹9.05 Lakh (FY 2019)••••••••7.0%••••New Delhi, Delhi, India
Bhartiya Pharmaceuticals India Private Limited₹9.05 Lakh (FY 2016)••••••••779.0%••••Indore, Madhya Pradesh, India

Peers are the five companies nearest above and the five nearest below Adils Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals Private Limited is audited by G SABHARWAL & COMPANY for the financial year 2017.

NameStatusAppointment DateCessation Date
G SABHARWAL & COMPANYLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Adils Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Adils Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Adils Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Yogesh Jee Sharma ceased to be Director on 12 Apr 2023.

AGM
Adils Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Adils Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Yogesh Jee Sharma ceased to be Director.
Appointed
Mano Ranjan Kumar was appointed as Director.
Appointed
Lalita Roy was appointed as Director.
Incorporation
20 Oct 2015
Adils Pharmaceuticals Private Limited was registered on 20 Oct 2015 with Roc Kanpur & aged 11 years 1 day as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Adils Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Adils Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Adils Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AANCA8638E1ZBUttar PradeshActive17 Oct 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Adils Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adils Pharmaceuticals Private Limited

Adils Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 October 2015 (11+ years old) and is registered under CIN U24233UP2015PTC073968.

Adils Pharmaceuticals reported revenue of ₹9.11 Lakh for FY 2024 (down 15% YoY).

Adils Pharmaceuticals has 2 current directors:

Adils Pharmaceuticals reported a net profit of ₹6,955 (net margin 0.8%) and EBITDA of ₹6,955 (EBITDA margin 0.8%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Adils Pharmaceuticals is 9% over three years and 26% over five years. In the latest year (FY 2024) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Adils Pharmaceuticals is 09AANCA8638E1ZB, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Adils Pharmaceuticals is U24233UP2015PTC073968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Adils Pharmaceuticals was incorporated on 20 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Adils Pharmaceuticals by revenue are Exevant Pharmaceuticals Private Limited, Sigmavet Pharmaceuticals Private Limited, Healthon Pharmaceuticals Private Limited, Atbu Harita Pharmaceuticals Private Limited, Livway Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Yogesh Jee Sharma ceased to be Director on 12 Apr 2023. Mano Ranjan Kumar was appointed as Director on 10 Apr 2023. Lalita Roy was appointed as Director on 20 Oct 2015.

The registered office of Adils Pharmaceuticals is at 246 C 1 Lda Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available